News - Page 163 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada

Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada

Post published:August 6, 2021
Post category:Psychedelic Bulletin

Read more about the article Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Post published:August 5, 2021
Post category:Press Release

Read more about the article PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Post published:August 5, 2021
Post category:Press Release

Read more about the article Silo Wellness Brings Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited

Silo Wellness Brings Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited

Post published:August 5, 2021
Post category:Press Release

Read more about the article Psygen Announces Successful Closing of Oversubscribed Convertible Debenture Financing, Sets Value at $30mm

Psygen Announces Successful Closing of Oversubscribed Convertible Debenture Financing, Sets Value at $30mm

Post published:August 5, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK

Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK

Post published:August 4, 2021
Post category:Press Release

Read more about the article Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals

Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals

Post published:August 4, 2021
Post category:News

Read more about the article Fireside Project Releases App for Psychedelic Peer Support

Fireside Project Releases App for Psychedelic Peer Support

Post published:August 4, 2021
Post category:Press Release

Read more about the article PsyBio Therapeutics Adds NMDA Receptor Antagonists and Associated Analogues into its Intellectual Property Portfolio

PsyBio Therapeutics Adds NMDA Receptor Antagonists and Associated Analogues into its Intellectual Property Portfolio

Post published:August 4, 2021
Post category:Press Release

Read more about the article Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin

Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin

Post published:August 3, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.